ANTI-ETANERCEPT ANTIBODIES AND ETANERCEPT LEVES LEVELS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW AND FULL-DOSE ETANERCEPT IN DAS28 REMISSION

被引：0
|
作者：
Ometto, F. [1 ]
Beggio, M. [1 ]
Friso, L. [1 ]
Astorri, D. [1 ]
Raffeiner, B. [1 ,2 ]
Botsios, C. [1 ]
Bernardi, L. [1 ]
Padoan, R. [1 ]
Punzi, L. [1 ]
机构：
[1] Univ Padua, Med Dept DIMED, Rheumatol Unit, Padua, Italy
[2] Gen Hosp Bolzano, Internal Med, Rheumatol Unit, Bolzano, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5841
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0178
引用
收藏
页码：494 / 494
页数：1
相关论文
共 50 条
  • [31] Clinical significance of anti-cyclic citrullinated peptide (CCP) antibodies in monitoring patients with rheumatoid arthritis (RA) treated with etanercept.
    Kekow, J
    Wollenberg, H
    Kuehne, C
    Polter, J
    Drynda, A
    Drynda, S
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S550 - S550
  • [32] Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-α
    den Broeder, AA
    Creemers, MCW
    van Gestel, AM
    van Riel, PLCM
    [J]. RHEUMATOLOGY, 2002, 41 (06) : 638 - 642
  • [33] CLINICAL IMPORTANCE OF ANTI-DRUG AND SERUM DRUG LEVEL TESTING IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ETANERCEPT
    Drynda, S.
    Kekow, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 499 - 500
  • [34] Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database
    Ostergaard, M.
    Unkerskov, J.
    Linde, L.
    Krogh, N. S.
    Ravn, T.
    Ringsdal, V. S.
    Petri, A.
    Andersen, L. S.
    Tarp, U.
    Hansen, A.
    Hjardem, E.
    Hetland, M. L.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2007, 36 (02)
  • [35] Results Of The Strass Trial Regarding Impact Of Progressive Spacing Of Tnf-Blocker Injections In Rheumatoid Arthritis Patients In Das28 Remission: Is There a Difference Between Drugs - Adalimumab and Etanercept - Or Their Mode Of Use - Monotherapy Or Combination?
    Fautrel, Bruno
    Thao Pham
    Morel, Jacques
    Alfaiate, Toni
    Dernis, Emmanuelle
    Gaudin, Philippe
    Brocq, Olivier
    Solau-Gervais, Elisabeth
    Berthelot, Jean-Marie
    Balblanc, Jean-Charles
    Mariette, Xavier
    Tubach, Florence
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S1150 - S1150
  • [36] COMPARISON OF ACR/EULAR AND DAS28 REMISSION CRITERIA IN A COHORT OF TNF INHIBITOR TREATED RHEUMATOID ARTHRITIS PATIENTS
    Balogh, E.
    Dias, J. M.
    Mullan, R.
    Harty, L. C.
    Gallagher, P.
    Molloy, M.
    O'Flynn, E.
    O'Kelly, A.
    O'Neill, M.
    Moore, L.
    Murray, M.
    FitzGerald, O.
    Fearon, U.
    Veale, D. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 213 - 213
  • [37] INCIDENCE OF ANTI-DRUG ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM ARGENTINA TREATED WITH ADALIMUMAB, ETANERCEPT, OR INFLIXIMAB IN A REAL-WORLD SETTING
    Maid, Pablo
    Real, Rosa
    Pedersen, Ron
    Shen, Qi
    Hidalgo, Rodolfo
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (03) : 131 - 131
  • [38] COST-EFFECTIVENESS OF THE USE OF ETANERCEPT VS ANTI-TNF MONOCLONAL ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN MEXICO
    Aguirre, A.
    Garcia, E.
    Bierschwale, H.
    Arce, C. A.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A522 - A523
  • [39] Effects of half dose etanercept (25 mg once a week) on clinical remission and radiographic progression in patients with rheumatoid arthritis in clinical remission achieved with standard dose
    Raffeiner, B.
    Botsios, C.
    Ometto, F.
    Bernardi, L.
    Stramare, R.
    Todesco, S.
    Sfriso, P.
    Punzi, L.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (01) : 63 - 68
  • [40] COMPARISON OF EFFECTS OF STANDARD- AND LOW-DOSE ETANERCEPT ON INFLAMMATORY SYNOVITIS IN RHEUMATOID ARTHRITIS PATIENTS AS ASSESSED BY ULTRASONOGRAPHY
    Mamoto, K.
    Koike, T.
    Okano, T.
    Sugioka, Y.
    Tada, M.
    Inui, K.
    Nakamura, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1010 - 1011
12345